| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |